[EN] HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS<br/>[FR] COMPOSÉS HÉTÉROARYLE ET LEUR UTILISATION COMME MÉDICAMENTS THÉRAPEUTIQUES
申请人:DONG-A SOCIO HOLDINGS CO LTD
公开号:WO2017039331A1
公开(公告)日:2017-03-09
The present invention provides heterocyclic compounds, the stereoisomer thereof, the enantiomer thereof, or the pharmaceutically acceptable salt, which are capable of modulating the activity of Mer receptor tyrosine kinase (MERTK). This invention also provides pharmaceutical compositions thereof, methods to prepare the said compounds, and the use of such compounds as a medicament. The present invention is directed to MERTK inhibitory compounds with marked potency, thereby having an outstanding potential for a pharmaceutical intervention of cancer and any other diseases related to MERTK dysregulation.
Derivatization and mass spectrometric investigations of substituted benzeneboronic acids. The use of linked scanning during gas chromatography mass spectrometry
作者:Colin Longstaff、Malcolm Edward Rose
DOI:10.1002/oms.1210171010
日期:1982.10
AbstractSubstituted benzeneboronic acids are important intermediates in the synthesis of support matrices for affinity chromatography but their analysis by mass spectrometry is hindered by thermal reactions in the ion source. A simple derivatization with 1,2‐ or 1,3‐diols removes this difficulty and imparts sufficient volatility for application of gas chromatography/mass spectrometry. The mass spectra of the resulting boronate esters are discussed with reference to high resolution measurements, isotope labelling studies and observation of metastable ions. ortho Substituents are shown to interact strongly during fragmentation. Linked scanning at constant B/E was used to characterize fragmentation pathways and the compatibility of linked scanning and GC/MS is reported.
Structural study of phenyl boronic acid derivatives as AmpC β-lactamase inhibitors
作者:Donatella Tondi、Samuele Calò、Brian K. Shoichet、Maria Paola Costi
DOI:10.1016/j.bmcl.2010.04.007
日期:2010.6
A small set of boronic acids acting as low nanomolar inhibitors of AmpC beta-lactamase were designed and synthesized in the effort to improve affinity, pharmacokinetic properties, and to provide a valid lead compound. X-ray crystallography revealed the binary complex of the best inhibitor bound to the enzyme, highlighting possibilities for its further rational derivatization and chemical optimization. (C) 2010 Elsevier Ltd. All rights reserved.
Torssell et al., Arkiv foer Kemi, 1957, vol. 10, p. 497,503